Zobrazeno 1 - 10 of 13 pro vyhledávání: '"Kevin, Yarasheski"'
1
Akademický článek
Plasma Aβ42/40 and cognitive variability are associated with cognitive function in Black Americans: Findings from the AA‐FAIM cohort
Autor: Barbara Fischer, Carol Ann Van Hulle, Rebecca Langhough, Derek Norton, Megan Zuelsdorff, Diane Carol Gooding, Mary F. Wyman, Adrienne Johnson, Nickolas Lambrou, Taryn James, Shenikqua Bouges, Fabu Phillis Carter, Hector Salazar, Kristopher Kirmess, Mary Holubasch, Matthew Meyer, Venky Venkatesh, Tim West, Philip Verghese, Kevin Yarasheski, Cynthia M. Carlsson, Sterling C. Johnson, Sanjay Asthana, Carey E. Gleason
Publikováno v: Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 9, Iss 3, Pp n/a-n/a (2023)
Abstract Introduction It is critical to develop more inclusive Alzheimer's disease (AD) research protocols to ensure that historically excluded groups are included in preclinical research and have access to timely diagnosis and treatment. If validate
Externí odkaz: https://doaj.org/article/eb13fdc76b2f4597a4d569cd5d18a274
Zobrazit plný text záznamu
2
Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer’s Disease
Autor: Charisse N. Winston, Oliver Langford, Natalie Levin, Rema Raman, Kevin Yarasheski, Tim West, Sara Abdel-Latif, Michael Donohue, Akinori Nakamura, Kenji Toba, Colin L. Masters, James Doecke, Reisa A. Sperling, Paul S. Aisen, Robert A. Rissman
Publikováno v: Journal of Alzheimer's Disease. 92:95-107
Background: Participant eligibility for the A4 Study was determined by amyloid PET imaging. Given the disadvantages of amyloid PET imaging in accessibility and cost, blood-based biomarkers may serve as a sufficient biomarker and more cost-effective s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5fd59f85aa61ed23fc962a76be568c9b
https://doi.org/10.3233/jad-221118
Zobrazit plný text záznamu
3
Age and amyloid effects on human central nervous system amyloid-beta kinetics
Autor: Bruce W, Patterson, Donald L, Elbert, Kwasi G, Mawuenyega, Tom, Kasten, Vitaliy, Ovod, Shengmei, Ma, Chengjie, Xiong, Robert, Chott, Kevin, Yarasheski, Wendy, Sigurdson, Lily, Zhang, Alison, Goate, Tammie, Benzinger, John C, Morris, David, Holtzman, Randall J, Bateman
Publikováno v: Annals of neurology. 78(3)
Age is the single greatest risk factor for Alzheimer's disease (AD), with the incidence doubling every 5 years after age 65. However, our understanding of the mechanistic relationship between increasing age and the risk for AD is currently limited. W
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5fdfa01c69a08c9305942c4efa962495
https://pubmed.ncbi.nlm.nih.gov/26040676
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje